Advertisement
Advertisement
U.S. markets open in 3 hours 45 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Hypera S.A. (HYPE3.SA)

São Paulo - São Paulo Delayed Price. Currency in BRL
Add to watchlist
45.65+1.40 (+3.16%)
At close: 05:07PM BRT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close44.25
Open0.00
Bid45.68 x 0
Ask45.54 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,952,350
Market Cap28.899B
Beta (5Y Monthly)0.51
PE Ratio (TTM)17.83
EPS (TTM)2.56
Earnings DateOct 28, 2022
Forward Dividend & Yield1.23 (2.78%)
Ex-Dividend DateSep 29, 2022
1y Target Est49.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for HYPE3.SA

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Reuters

      UPDATE 1-Brazilian drugmaker Hypera's talks with rivals not currently active, source says

      Brazilian pharmaceutical company Hypera has discussed a takeover offer from rival company NC Group, the owner of EMS SA, but talks are not currently active, one source with knowledge of the matter said on Wednesday. Hypera has also discussed a sale to local pharmaceutical company Eurofarma, the source added. Hypera's controlling shareholder, Joao Alves de Queiroz Filho, has a 21% stake in the company and a shareholder agreement with Mexican holding Maiorem SA de CV owns another 15%.

    • Reuters

      Brazilian drugmaker Hypera's talks with rivals not currently active -source

      Brazilian pharmaceutical company Hypera has discussed a takeover offer from rival company NC Group, the owner of EMS SA, but talks are not currently active, one source with knowledge of the matter said on Wednesday. Hypera has also discussed a sale to local pharmaceutical company Eurofarma, the source added. Hypera's controlling shareholder, Joao Alves de Queiroz Filho, has a 21% stake in the company and a shareholder agreement with Mexican holding Maiorem SA de CV owns another 15%.

    • Reuters

      Brazil's Hypera shares jump after leniency agreement with authorities

      Shares in Brazilian drugmaker Hypera SA rose 6% on Wednesday after it entered into a long-expected leniency agreement with the country's authorities related to investigations into illegal payments by former executives to public officials. The agreement, struck with Brazil's federal comptroller CGU and solicitor general AGU and announced on Tuesday, includes a fine of 110 million reais ($22.98 million), which will be paid by the company's founding shareholder Joao Alves de Queiroz Filho, with no cash impact for Hypera. JPMorgan analysts welcomed the agreement, saying it settled a long-term issue with the company's governance.

    Advertisement
    Advertisement